Product Information
FONDAPARINUX 10 MG/0.8 ML SYR is a generic product labeled by Eugia US LLC, priced at $45.3441 per ML under NDC 55150023310. Its NADAC has been published 206 times since Jul 20, 2022.
Strength
10 mg/.8mL
Manufacturer
Eugia US LLCNDC
55150023310
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206918On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has been published 206 times since Jul 20, 2022, and over the history we have for it it has declined 9.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $45.3441 per ML |
|---|---|
| All-time high | $53.5408 (May 15, 2024) |
| All-time low | $29.5253 (May 21, 2025) |
| 52-week high | $45.3441 |
| 52-week low | $30.5618 |
| Median price | $40.3835 |
| Average price | $43.0641 |
| Largest weekly change | -26.6% (May 22, 2024) |
| Weeks tracked | 206 |
| Tracking since | Jul 20, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FONDAPARINUX 10 MG/0.8 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 10 MG/0.8 ML SYR, manufactured by Eugia US LLC, is $45.3441 per ML (NDC 55150023310), effective Jun 24, 2026.
How has the price of FONDAPARINUX 10 MG/0.8 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has declined 9.4%. It has been tracked across 206 weekly CMS publications since Jul 20, 2022.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 10 MG/0.8 ML SYR?
Since Jul 20, 2022, the NADAC for FONDAPARINUX 10 MG/0.8 ML SYR has ranged from a low of $29.5253 (May 21, 2025) to a high of $53.5408 (May 15, 2024), with a median of $40.3835 per ML.
Are there cheaper alternatives to FONDAPARINUX 10 MG/0.8 ML SYR?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FONDAPARINUX 10 MG/0.8 ML SYR, so no direct lower-cost alternative is listed.
Who manufactures FONDAPARINUX 10 MG/0.8 ML SYR?
FONDAPARINUX 10 MG/0.8 ML SYR (NDC 55150023310) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification